Agilent Technologies (Agilent Technologies) Change In Receivables : $147 Mil (TTM As of Jan. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Agilent Technologies Change In Receivables?

Agilent Technologies's change in receivables for the quarter that ended in Jan. 2024 was $10 Mil. It means Agilent Technologies's Accounts Receivable declined by $10 Mil from Oct. 2023 to Jan. 2024 .

Agilent Technologies's change in receivables for the fiscal year that ended in Oct. 2023 was $132 Mil. It means Agilent Technologies's Accounts Receivable declined by $132 Mil from Oct. 2022 to Oct. 2023 .

Agilent Technologies's Accounts Receivable for the quarter that ended in Jan. 2024 was $1,295 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Agilent Technologies's Days Sales Outstanding for the three months ended in Jan. 2024 was 71.27.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Agilent Technologies's liquidation value for the three months ended in Jan. 2024 was $-1,524 Mil.

Agilent Technologies Change In Receivables Historical Data

The historical data trend for Agilent Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilent Technologies Change In Receivables Chart

Agilent Technologies Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Change In Receivables

Get a 7-Day Free Trial

-106.00

-107.00

-128.00

-321.00

132.00

Agilent Technologies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Change In Receivables	Get a 7-Day Free Trial															-5.00	54.00	64.00	19.00	10.00

Agilent Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $147 Mil.

Agilent Technologies (NYSE:A) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Agilent Technologies's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1295	/	1658	*	91
=	71.27

2. In Ben Graham's calculation of liquidation value, Agilent Technologies's accounts receivable are only considered to be worth 75% of book value:

Agilent Technologies's liquidation value for the quarter that ended in Jan. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1748	-	4760	+	0.75 * 1295	+	0.5 * 1033
=	-1,524

Agilent Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Agilent Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Agilent Technologies (Agilent Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Agilent Technologies Inc (NYSE:A) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

A:Mexico 1A:Italy AG8:Germany AG8:Germany

Address

5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051

Website

https://www.agilent.com

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Executives

Philip Binns	officer: Senior Vice President	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Rodney Gonsalves	officer: V.P., Corporate Controller	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Henrik Ancher-jensen	officer: Sr. Vice President	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Michael R. Mcmullen	officer: CEO and President	5301 STEVENS CREEK BLVD., MS 1A-LC, SANTA CLARA CA 95051
George A Scangos	director	C/O EXELIXIS INC, 170 HARBOR WAY, SAN FRANCISCO CA 94083
Otis W Brawley	director	5203 BRISTOL INDUSTRIAL WAY, BUFORD GA 30518
Mikael Dolsten	director	5 GIRALDA FARMS, MADISON NJ 07940
Mala Anand	director	C/O COTIVITI HOLDINGS, INC., 115 PERIMETER CENTER PLACE, SUITE 700, ATLANTA GA 30346
Sue H. Rataj	director	C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Dow R Wilson	director	VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Boon Hwee Koh	director	C/O AGILENT TECHNOLOGIES, 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Heidi Fields	director	5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Hans Edgar Bishop	director	60 WEST 66TH STREET, 26A, NEW YORK NY 10023
Daniel K Podolsky	director	5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Padraig Mcdonnell	officer: Senior Vice President	5301 STEVENS CREEK BLVD, SANTA CLARA CA 95051